CROHN'S DISEASE AND ULCERATIVE COLITIS

Clinical trials for CROHN'S DISEASE AND ULCERATIVE COLITIS explained in plain language.

Never miss a new study

Get alerted when new CROHN'S DISEASE AND ULCERATIVE COLITIS trials appear

Sign up with your email to follow new studies for CROHN'S DISEASE AND ULCERATIVE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug trial aims to tame debilitating gut diseases

Disease control Not yet recruiting

This study is testing how well and how safely a drug called an IL-23 monoclonal antibody works for people with moderate to severe Crohn's disease or ulcerative colitis. It will follow 200 adult patients for about a year, checking their symptoms, doing scans and scopes, and collec…

Matched conditions: CROHN'S DISEASE AND ULCERATIVE COLITIS

Phase: PHASE4 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

CROHN'S DISEASE AND ULCERATIVE COLITIS

Get alerted when new CROHN'S DISEASE AND ULCERATIVE COLITIS trials appear

New drug trial aims to tame debilitating gut diseases